Related Experiment Video
Updated: Dec 28, 2025

07:40
Determining Ciliary Function and Membrane Impermeability of the Pseudostratified Lung Airway Epithelium
Published on: February 21, 2025
1.1K
Mucociliary clearance mechanism in interstitial lung disease
The Tohoku Journal of Experimental Medicine
|February 1, 1986
Summary
Mucociliary clearance mechanisms remain effective in patients with interstitial lung diseases like pulmonary interstitial fibrosis and sarcoidosis. Lung function tests revealed abnormalities only in pulmonary interstitial fibrosis, not sarcoidosis.
Area of Science:
- Pulmonary Medicine
- Respiratory Physiology
Background:
- Interstitial lung diseases (ILDs) encompass conditions like pulmonary interstitial fibrosis and sarcoidosis.
- Assessing lung function and clearance mechanisms is crucial for understanding ILD progression.
Purpose of the Study:
- To evaluate the mucociliary clearance mechanisms in patients with pulmonary interstitial fibrosis and sarcoidosis.
- To correlate lung function test results with observed clearance mechanisms.
Main Methods:
- Study included 14 patients with pulmonary interstitial fibrosis and 8 with sarcoidosis.
- Methods involved lung function tests and radioaerosol inhalation lung cine-scintigraphy.
Main Results:
- All patients exhibited interstitial densities on chest x-rays.
- Pulmonary interstitial fibrosis patients showed restrictive and diffusion abnormalities on lung function tests.
- Sarcoidosis patients did not exhibit these specific functional abnormalities.
- Mucociliary clearance mechanisms were found to be well-maintained in both patient groups.
Conclusions:
- Mucociliary clearance is largely preserved in patients with pulmonary interstitial fibrosis and sarcoidosis.
- Lung function abnormalities in ILDs do not necessarily correlate with impaired mucociliary clearance.
Related Concept Videos
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.1K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.1K
Cystic Fibrosis: Management
394
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
394
Drugs Used in Upper Respiratory Disorders: Overview
559
Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
559
Cystic Fibrosis: Pathogenesis
650
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
650

